Market Overview

The global Cardiovascular Needles Market in terms of revenue was estimated to be worth $ 92.11 Million in 2023 and is poised to reach $ 170.76 Million by 2032, growing at a CAGR of 7.10% from 2024 to 2032.

The cardiovascular needles market is based on a highly specialized type of surgical needle that finds use in the suturing process during various cardiovascular surgeries, such as open-heart surgeries, coronary artery bypass grafting, and valve repairs. These are needles specially designed to handle fragile cardiovascular tissues, minimize trauma to surrounding structures, and make accurate suturing possible in the very complex anatomy of the heart and blood vessels. Usually, they are made of stainless steel, titanium, or alloyed metal, which gives the required strength, flexibility, and precision in high-risk cardiovascular operations to ensure safe efficient surgery.

The global cardiovascular disease prevalence rate also drives this market. Hypertension, diabetes, and obesity have significantly contributed to the rise in CVD rates. Other lifestyle factors include smoking, sedentary behaviour, and high-stress levels. Heart disease is the number one cause of death globally, which is why there is a massive demand for cardiovascular surgeries and interventions as early diagnosis rates improve. A high proportion of the ageing population are susceptible to CVD, and hence their surgical treatment has become high in demand. Therefore, the specialized cardiovascular needles answering the needs of the cardiac procedure have increased in demand as well.

Advancements in medical technology further influence this market due to the reason that the manufacturers are currently busy in the designing and enhancing the function of cardiovascular needles. With an improvement in manufacturing processes comes a more ergonomic needle design allowing for greater control by the surgeon. Advances in the coating of needles also lead to less tissue trauma, sutures that last longer, and, therefore, recovery times are shorter for the patient. Most needles may be used with minimally invasive procedures, which, by the way, have become much more common today than they were before. A low incidence of complications and quicker recovery times due to preference for minimally invasive cardiovascular procedures translate into increased demand for precision instruments such as specialized cardiovascular needles.

North America and Europe lead the geographical extent due to developed healthcare infrastructures holding a high number of procedures regarding cardiovascular disease, together with well-established pipelines in researching medicine. The highest potential growth in the Asia-Pacific region is also observed the market will be led forward as the healthcare expenditures have experienced an increase, along with greater incidence rates of CVD, and the enhancement in medical infrastructures.

The cardiovascular needles market is basically a part of the comprehensive surgical instruments sector, largely driven by the increasing trend of cardiovascular diseases, needle technology advancements, and more than anything, the adoption of minimally invasive interventions around the world. While continued innovation and heightened healthcare demands keep on fuelling this trend, the market is forecasted to grow steadily in coming years.

Key Findings

• In April 2024, California X-ray Imaging Services, Inc. is now a subsidiary of Shimadzu Precision Instruments, Inc. (hence, “SPI”), which Shimadzu Corporation (hereinafter, “Shimadzu”) bought all of the company's shares through. CIS will be integrated into SPI's medical systems branch, Shimadzu Medical Systems USA (henceforth referred to as "SMS").
• In Jan 2024, GE HealthCare announced that it has reached a deal to buy MIM Software, a global supplier of artificial intelligence (AI) and medical imaging analysis solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centres, hospitals, speciality clinics, and research firms worldwide.

Market Dynamics - Market Drivers

Rising Incidence of Cardiovascular Diseases (CVDs)

The death rate worldwide is largely because of cardiovascular diseases. According to a report, over 17 million deaths take place each year due to this condition. CVDs are rising due to some of the risk factors including an aging population, lack of exercise, unhealthy diets, smoking, hypertension, and diabetes. Aging is considered to be the largest factor for risks of cardiovascular problems. The heart and blood vessels change with age and have an increased susceptibility to the risk of heart disease. More fundamentally, sedentary life patterns and inappropriate dietary consumption cause obesity, high cholesterol levels, and hypertension, leading to cardiovascular health strain. Smoking further enhances these tendencies because it causes damage on blood vessels and increases deposition of plaques. Additionally, direct causes of heart and vascular complications include hypertension and diabetes.

The more the population affected by these cardiovascular health issues, the greater the demand for surgeries of the cardiovascular system and therefore, the need for special surgical equipment, like a cardiovascular needle. These are highly significant for procedures that entail fine suturing of very thin tissues in the cardiovascular systems and therefore, are fundamental in effective treatment of the CVDs and control of heart health.

Key Findings

• In April 2022, Mediso Ltd announced the acquisition of Bartec Technologies Ltd, a UK-based company specializing in the supply, installation, and support of Nuclear Medicine and Molecular Imaging equipment and accessories. This acquisition is expected to strengthen Mediso’s position in the UK and Ireland markets

Market Opportunities

Growing Demand for Minimally Invasive Surgeries

The demand for minimally invasive cardiovascular procedures has increased substantially because these techniques have advantages in terms of shorter recovery times, fewer complications, and fewer traumas than open-heart surgeries. This is mainly because the patients demand less invasive treatment that allows them to return as soon as possible to normal activities and fewer postoperative complications. It will, therefore, lead to a huge opportunity in cardiovascular needles market as these require specialized high-precision needles for good performance in constrained surgical environment.

Cardiovascular needle manufacturers are increasingly developing such cardiovascular needles that are compatible with minimally invasive techniques of endoscopic and laparoscopic approaches. Such specialized needles, while smaller and flexible to allow for a minimally invasive approach, would still retain precision and reliability. These demand needs will continue driving the innovation of needle designs and material composition as companies attempt to upgrade the performance of their products. As the number of these minimally invasive cardiovascular interventions continues to rise, the market demand for relevant surgical equipment shall thus remain constantly augmented.

Key Findings

• In May 2023, Koninklijke Philips N.V., Elekta, and Mercurius Health announced a 3-year agreement, under which Philips and Elekta installed the diagnostic & therapeutic oncology equipment and aligned informatics solutions at Mercurius Health’s newly acquired Robert Janker Klinik cancer center in Bonn, Germany

Market Restraining Factors

High Cost of Cardiovascular Surgeries and Equipment

High tech specialized surgery for the cardiovascular category has been one of those requiring high investment, resulting in posing a big financial limitation among patients and healthcare sectors too. It is really not low-cost procedures because those specialized equipment, skilled surgeon operation, and extended after-surgery care are major financial burdens for both hospital departments and the patients. It can be especially challenging for patients from low- and middle-income countries because, in those areas, the healthcare resources are mostly limited. Advanced cardiovascular surgeries are very costly. It might not always be in the budget to purchase medical supplies regularly in those regions. For instance, in specialized cardiovascular procedures, needles of certain types must be used to ensure proper suturing.

Many hospitals would opt for lower-priced, multi-purpose types or wait until newer, higher-priced needle technologies became affordable. Such a restriction in the use of superior surgical tools can lead to undesirable outcomes during surgery. Again, due to high-priced cardiovascular needles, many people will not be able to access the needles on a wide scale, because a good doctor has to choose between quality and budget; the penetration rate in a given area would be reduced because of the high costs.

Segmentation Analysis

The market scope is segmented because of by Type, by Application, by Usage, by End User.

By Type

Based on the Type of the market is segmented into Taper Point Needles, Cutting Needles.

Taper point needles are highly preferred, which have rounded tips, so they enter the soft tissues easily without much difficulty and are considered suitable for cardiovascular surgeries since they would not cause the maximum amount of trauma, so in the suturing of heart valves and delicate blood vessels, precision plays a major role to attain better healing with minimum complications. For example, in mitral valve repair surgery, taper point needles allow the surgeon to sew the heart valve tissue very delicately without causing more damage to it for a better recovery.

Cutting needles are made with an edge, thus suitable for tougher tissues which require more cutting ability. These are useful in procedures involving fibrous tissues such as the pericardium or pericardium. For instance, cut needles are utilized during the closure of thoracotomy, in which deeper tissue penetration by suture is necessary. Using both the types of needles addresses different needs in cardiovascular procedures such that the general efficacy and safety of surgical interventions are maintained.

By Application

Based on the Application of the market is segmented into Open-Heart Surgery, Minimally Invasive Cardiovascular Surgery.

The open-heart surgery segment accounts for the largest share of the cardiovascular needles market, with traditional procedures such as CABG and valve repair. These surgeries require special needles to ensure precise suturing of delicate cardiovascular tissues. For example, in a CABG procedure, surgeons stitch grafts onto coronary arteries using taper point needles to minimize tissue trauma and ensure effective healing. Open-heart surgeries are very critical and complex, and thus good quality needles would be required to improve surgical outcomes.

The minimally invasive cardiovascular surgery segment is increasing at a very fast pace due to advancements in surgical techniques, including endoscopic and laparoscopic approaches. These require special needles, which can be used in confined spaces, and surgeons can do very intricate work with great precision. Many demand this product because the available advantages include reduced recovery periods and fewer complications. For instance, surgeons who do a laparoscopic closure of atrial sepal defect depend more on specific needles that are instruments in the confined area in the course of the surgical process wherein one patient has an early recovery or lesser complications experienced by some patients after the surgical period. Both segments prove their usefulness through the help of individual-specific needles, thereby improving the efficiency when working on surgery that reduces risks to the surgical patient.

Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America dominates the market share, primarily because of its strong healthcare system, high prevalence of cardiovascular disease, and strong presence of leading manufacturers. The demand is mainly from the United States, as complex surgical procedures like CABG and valve repairs are quite common. Such is the reason why the region is innovating more in terms of advances in the design and functionality of needles.

The other major market is Europe. Germany, France, and the United Kingdom contribute greatly in the overall growth of the cardiovascular needle. It boasts high healthcare expenditure, an advanced medical device industry, and growing health consciousness in respect to the cardiovascular area. The overall quality of the surgical instrument, considering very stringent regulatory standards concerning the safety and efficacy parameters of Europe, contributes positively toward the market's growth.

The Asia-Pacific region has been undergoing rapid growth in the market of cardiovascular needles mainly on account of enhanced healthcare spending and an aged population prone to more cardiovascular diseases. There are also rising healthcare infrastructures in China and India that give them a fair opportunity to tap into leading-edge surgical practice. More preponderance of risk factors related to lifestyle like obesity and diabetes is acting as another push for more cardiovascular surgeries that will correspondingly lead to the higher demand for needles used in this treatment in the Asia-Pacific region.

New region in cardiovascular needles includes Latin America and the Middle East and Africa, where awareness of cardiovascular diseases is growing with the demand for better health care provision. In Latin America, it is seen that countries like Brazil and Mexico are investing in health care improvement and gradually adopting advanced surgical procedures. The demand for specialty surgical instruments in the Middle East and Africa is rising with the emergence of more healthcare facilities, along with an increase in cardiovascular diseases. However, economic disparities and lack of homogeneous access to healthcare services could decelerate growth in these regions.

The cardiovascular needles market is likely to increase in various regions; the development of healthcare infrastructure, increased incidence of cardiovascular diseases, and a continuous trend toward less invasive surgical procedures have influenced this. The more developed the healthcare system worldwide is, the more demand will be created for quality-specialized cardiovascular needles to enhance patient outcomes and the efficiency of surgery.

List of Companies Profiled

• Barber of Sheffield Ltd.
• CP Medical Inc.
• Ethicon US LLC
• MANI Inc.
• FSSB surgical needles GmbH SMB Corporation
• Quality Needles Pvt. Ltd.
• BD
• Braun Melsungen AG
• SMB Corporation of India
• KLS Martin Group
• Sklar Surgical Instruments
• Scanlan International
• Teleflex Incorporated
• Medline Industries Inc.
• Surtex Instruments Limited
• Symmetry Surgical Inc.
• Delacroix-Chevalier
• Wexler Surgical
• Aurolab and RK Manufacturing

Key Industry Developments

• In September 2024, Leading international medical technology business BD (Becton, Dickinson and business) announced that it has successfully acquired the Critical Care product group from Edwards Lifesciences. The new company will be called BD Advanced Patient Monitoring.
• In July 2023, Leading international medical technology provider Teleflex Incorporated said it has finalised a deal to buy privately held Palette Life Sciences AB for $600 million in cash at closing, with an additional $50 million paid if certain commercial milestones are met.
• In September 2022, Leading infusion treatment and pain management company B. Braun Medical Inc. (B. Braun) announced that it has purchased Starboard Medical, Inc.'s cutting-edge Clik-FIX catheter securement device portfolio.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Cardiovascular Needles Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Cardiovascular Needles market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Cardiovascular Needles. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Cardiovascular Needles companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Cardiovascular Needles Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Cardiovascular Needles Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Cardiovascular Needles Market valued?
• Which region has the largest share in 2024 for the global Cardiovascular Needles Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of the Market

• Historic year: 2019- 2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Million

Cardiovascular Needles Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: